Insulin-Pumps-Medical-Devices-Pipeline-Assessment-2016

Comments

Transcription

Insulin-Pumps-Medical-Devices-Pipeline-Assessment-2016
Insulin Pumps - Medical Devices Pipeline
Assessment, 2016
No of Pages – 107
Publishing Date - May 9, 2016
Insulin Pumps - Medical Devices Pipeline Assessment, 2016
Summary
GlobalData's Medical Devices sector report, “Insulin Pumps - Medical Devices Pipeline Assessment,
2016" provides an overview of Insulin Pumps currently in pipeline stage.
The report provides comprehensive information on the pipeline products with comparative analysis
of the products at various stages of development. The report reviews major players involved in the
pipeline product development. It also provides information about clinical trials in progress, which
includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Insulin
Pumps pipeline products.
This report is prepared using data sourced from in-house databases, secondary and primary research
by GlobalData's team of industry experts.
*Note: Certain sections in the report may be removed or altered based on the availability and
relevance of data in relation to the equipment type.
Scope
- Extensive coverage of the Insulin Pumps under development
- The report reviews details of major pipeline products which includes, product description,
licensingand collaboration details and other developmental activities
- The report reviews the major players involved in the development of Insulin Pumps and list all
theirpipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early
Development to Approved / Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment / industry
Reasons to buy
The report enables you to - Formulate significant competitor information, analysis, and insights to improve R&D strategiesIdentify emerging players with potentially strong product portfolio and create effective
counterstrategies to gain competitive advantage
- Identify and understand important and diverse types of Insulin Pumps under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most
promisingpipeline
- In-depth analysis of the product’s current stage of development, territory and estimated launch date
Ask for Discount at – http://www.marketreportsworld.com/enquiry/request-discount/10160238
1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 5
1.2 List of Figures 7
2 Introduction 8
2.1 Insulin Pumps Overview 8
3 Products under Development 9
3.1 Insulin Pumps - Pipeline Products by Stage of Development 9
3.2 Insulin Pumps - Pipeline Products by Segment 10
3.3 Insulin Pumps - Pipeline Products by Territory 11
3.4 Insulin Pumps - Pipeline Products by Regulatory Path 12
3.5 Insulin Pumps - Pipeline Products by Estimated Approval Date 13 3.6 Insulin Pumps - Ongoing
Clinical Trials 14
4 Insulin Pumps - Pipeline Products under Development by Companies 15
4.1 Insulin Pumps Companies - Pipeline Products by Stage of Development 15
4.2 Insulin Pumps - Pipeline Products by Stage of Development 16
5 Insulin Pumps Companies and Product Overview 17
5.1 Amrita Vishwa Vidyapeetham Company Overview 17
5.1.1 Amrita Vishwa Vidyapeetham Pipeline Products & Ongoing Clinical Trials Overview 17
5.2 Andain, Inc Company Overview 19
5.2.1 Andain, Inc Pipeline Products & Ongoing Clinical Trials Overview 19
5.3 Cellnovo Ltd. Company Overview 21
5.3.1 Cellnovo Ltd. Pipeline Products & Ongoing Clinical Trials Overview 21
5.4 CeQur SA Company Overview 25
5.4.1 CeQur SA Pipeline Products & Ongoing Clinical Trials Overview 25
5.5 ConvaTec Healthcare B S.a.r.l. Company Overview 27
5.5.1 ConvaTec Healthcare B S.a.r.l. Pipeline Products & Ongoing Clinical Trials Overview 27
5.6 Debiotech S.A. Company Overview 28
5.6.1 Debiotech S.A. Pipeline Products & Ongoing Clinical Trials Overview 28
5.7 Hospira, Inc. Company Overview 31
5.7.1 Hospira, Inc. Pipeline Products & Ongoing Clinical Trials Overview 31
5.8 Insulet Corporation Company Overview 33
5.8.1 Insulet Corporation Pipeline Products & Ongoing Clinical Trials Overview 33
5.9 InsuLine Medical Ltd. Company Overview 36
5.9.1 InsuLine Medical Ltd. Pipeline Products & Ongoing Clinical Trials Overview 36
5.10 LifeScan, Inc. Company Overview 40
5.10.1 LifeScan, Inc. Pipeline Products & Ongoing Clinical Trials Overview 40
5.11 MedSolve Technologies, Inc. Company Overview 42
5.11.1 MedSolve Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview 42
5.12 Medtronic plc Company Overview 43
5.12.1 Medtronic plc Pipeline Products & Ongoing Clinical Trials Overview 43
5.13 MicroPort Scientific Corporation Company Overview 47
5.13.1 MicroPort Scientific Corporation Pipeline Products & Ongoing Clinical Trials Overview 47
5.14 NanoMed Ltd Company Overview 50
5.14.1 NanoMed Ltd Pipeline Products & Ongoing Clinical Trials Overview 50
5.15 Phluid Corporation Company Overview 51
5.15.1 Phluid Corporation Pipeline Products & Ongoing Clinical Trials Overview 51
5.16 Sensile Medical AG Company Overview 52
5.16.1 Sensile Medical AG Pipeline Products & Ongoing Clinical Trials Overview 52
5.17 SFC Fluidics LLC Company Overview 55
5.17.1 SFC Fluidics LLC Pipeline Products & Ongoing Clinical Trials Overview 55
5.18 Spring Health Solutions Ltd. Company Overview 56
5.18.1 Spring Health Solutions Ltd. Pipeline Products & Ongoing Clinical Trials Overview 56
5.19 Tandem Diabetes Care, Inc. Company Overview 57
5.19.1 Tandem Diabetes Care, Inc. Pipeline Products & Ongoing Clinical Trials Overview 57
5.20 ViCentra B.V. Company Overview 59
5.20.1 ViCentra B.V. Pipeline Products & Ongoing Clinical Trials Overview 59
5.21 Ypsomed Holding AG Company Overview 60
5.21.1 Ypsomed Holding AG Pipeline Products & Ongoing Clinical Trials Overview 60
6 Insulin Pumps- Recent Developments 63
6.1 Apr 28, 2016: Greatbatch Reports 2016 First Quarter Results 63
6.2 Apr 28, 2016: Tandem Diabetes Care Reports First Quarter 2016 Financial Results and Updates
2016 Guidance 65
6.3 Apr 13, 2016: New Data Shows Benefits of Medtronic Insulin Pumps for People with Type 2
Diabetes 66
6.4 Apr 06, 2016: Medtronic Statement on U.S. Department of Treasury's Recent Temporary and
Proposed Regulations 67
6.5 Mar 17, 2016: Medtronic Proposes Proxy Access 67
6.6 Mar 14, 2016: DECN Subsidiaries Sue Johnson & Johnson and Several Divisions for Patent
Infringement 67
6.7 Mar 14, 2016: Tandem Diabetes Care Announces Appointment of Dr. Henry Anhalt as Board
Member 67
6.8 Mar 01, 2016: Medtronic Reports Third Quarter Financial Results 68
6.9 Feb 29, 2016: Greatbatch Reports 2015 Fourth Quarter and Full Year Results 69
6.10 Feb 25, 2016: Insulet Enters into Licensing Agreement with Mode AGC 72
6.11 Feb 24, 2016: Ypsomed expands the distribution of mylife OmniPod in Europe 73
6.12 Feb 24, 2016: Tandem Diabetes Care Reports Fourth Quarter and Full Year 2015 Financial
Results 73
6.13 Feb 19, 2016: Medtronic to Announce Financial Results for Its Third Quarter of Fiscal Year
2016 74
6.14 Feb 02, 2016: Tandem Diabetes Care Expands Commercial Leadership 74
6.15 Jan 29, 2016: Liberty Medical to Acquire Neighborhood Diabetes from Insulet for USD5
Million 75
6.16 Jan 11, 2016: FDA Approves Animas Vibe Insulin Pump and Continuous Glucose Monitoring
System For Use in Children 75
6.17 Jan 11, 2016: Medtronic and Chengdu Sign Insulin Pump Manufacturing Agreement 76
6.18 Jan 11, 2016: Medtronic Updates Capital Allocation Plans and Fiscal 2016 EPS Guidance 76
6.19 Jan 11, 2016: Greatbatch Provides Preliminary 2015 Revenue Results and 2016 Guidance 77
6.20 Dec 28, 2015: Registration of Dongguan Kewei Occluder Series Products in Kazakhstan
Approved 77
6.21 Dec 14, 2015: The Medtronic Bakken Invitation Award Honors 12 Patients from Around the
World for Giving Back 78
6.22 Dec 02, 2015: MicroPort Orthopedics Attend the Tenth Session of the COA International
Conference 78
6.23 Nov 26, 2015: Two Subsidiaries of MicroPort Recognized as One of Shanghai's the First Group
of High-tech Enterprise 80
6.24 Nov 20, 2015: Medtronic Statement on U.S. Department of Treasury's Notice 2015-79 80
6.25 Nov 17, 2015: Tandem Diabetes Care Announces Retirement of Board Chairman Lonnie Smith;
Dick Allen Appointed as Successor Chairman 80
6.26 Oct 29, 2015: Tandem Diabetes Care Reports Third Quarter 2015 Financial Results 81
6.27 Oct 29, 2015: Greatbatch Reports 2015 Third Quarter Results 82
6.28 Oct 13, 2015: Greatbatch Raises USD360 Million in Private Placement of 9.125% Notes Due
2023 84
6.29 Sep 28, 2015: Medtronic InFuse Lawsuit May Reach Supreme Court, Parker Waichman LLP
Comments 85
6.30 Sep 09, 2015: MicroPort Scientific Corporation Announce Leadership Changes in MicroPort
Orthopedics Subsidiary and Membership Changes in CEC, IEC 85
6.31 Sep 03, 2015: Medtronic Reports First Quarter Financial Results 86
6.32 Sep 01, 2015: MPSC New COO Appointment - Jason Zhang 89
6.33 Aug 26, 2015: Greatbatch Partners with Wireless Power Leader WiTricity to Provide Wireless
Charging for Medical Devices 89
6.34 Aug 04, 2015: NICE draft guidance recommends integrated automatic glucose monitoring
system for people with type 1 diabetes 90
6.35 Aug 04, 2015: Animas Collaborates with Tidepool to Integrate Insulin Pump Data to OpenSource Software Aiding Diabetes Management 91
6.36 Jul 30, 2015: Tandem Diabetes Care Enters into Co-Development Agreement with Dexcom 92
6.37 Jul 30, 2015: Greatbatch Reports 2015 Second Quarter Results 92
6.38 Jul 30, 2015: Tandem Diabetes Care Reports Second Quarter 2015 Financial Results 94
6.39 Jul 24, 2015: Medtronic MiniMed Recalls MiniMed 620G and 640G Insulin Pumps 95
6.40 Jun 19, 2015: cellnovo starts the expansion of its distribution network 95
6.41 Jun 08, 2015: BD Medical Partners with Medtronic for Infusion Set 96
6.42 Jun 08, 2015: Tandem Diabetes Care Announces t:simulator App Now Available for Android
Devices 96
6.43 Jun 05, 2015: Algostim to be Renamed Nuvectra 96
6.44 Jun 03, 2015: Glooko Enters into Agreement with Dexcom 97
6.45 Jun 02, 2015: Medtronic Reports Fourth Quarter and Fiscal Year 2015 Financial Results 97
6.46 May 19, 2015: Tandem Diabetes Care Launches t:flex Insulin Pump 100
6.47 May 19, 2015: Medtronic Announces Preliminary Fourth Quarter and Fiscal Year 2015
Revenue Results 100
7 Appendix 104
7.1 Methodology 104
7.2 About GlobalData 106
7.3 Contact Us 107
7.4 Disclaimer 107
Report Details –
Date of Publishing - May 9, 2016
No of Pages – 107
Single User PDF License – $2500
Corporate License – $7500
Buy Now - http://www.marketreportsworld.com/purchase/10160238
About Market Reports World: Market Reports World is the credible source for gaining the market
research reports that will exponentially accelerate your business. We are among the leading report
resellers in the business world committed towards optimizing your business. The reports we provide
are based on a research that covers a magnitude of factors such as technological evolution, economic
shifts and a detailed study of market segments.
Contact–
Mr. Ameya Pingaley
Market Reports World
+1-408 520 9750
Email – [email protected]
www.marketreportsworld.com
Powered by TCPDF (www.tcpdf.orPowered by TCPDF (www.tcpdf.orgg) )